Zinc Status and Growth in Cystic Fibrosis

CompletedOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

August 29, 2019

Primary Completion Date

March 30, 2021

Study Completion Date

March 30, 2021

Conditions
CysticFibrosis
Interventions
BIOLOGICAL

Serum Zn

The investigators will obtain an additional 2 mL of blood in an extra tube. This will be collected at the same time blood is collected for the participant's yearly CF screening labs so as to minimize additional needle sticks.

BIOLOGICAL

Red Blood Cell Zn

If the participant is greater or equal than 5 kg, an additional 2 mL of blood will be obtained in an extra tube. This will be collected at the same time blood is collected for the participant's yearly CF screening labs so as to minimize additional needle sticks.

Trial Locations (1)

46202

Riley Hospital for Children at Indiana University Health, Indianapolis

All Listed Sponsors
lead

Indiana University

OTHER

NCT04302428 - Zinc Status and Growth in Cystic Fibrosis | Biotech Hunter | Biotech Hunter